Crispr Therapeutics shares owned by Lincoln Capital
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Lincoln Capital
from 13F filings
Historical chart of Lincoln Capital investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Lincoln Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Lincoln Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $205k | 3.0k | 68.16 |
2023-09-30 | $204k | 4.5k | 45.39 |